American International Group’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-16,026
| Closed | -$46K | – | 3222 |
|
|
2022
Q1 | $46K | Sell |
16,026
-1,128
| -7% | -$2.92K | ﹤0.01% | 2873 |
|
|
2021
Q4 | $52K | Sell |
17,154
-514
| -3% | -$2.23K | ﹤0.01% | 2945 |
|
|
2021
Q3 | $124K | Sell |
17,668
-235
| -1% | -$1.76K | ﹤0.01% | 2697 |
|
|
2021
Q2 | $164K | Sell |
17,903
-79
| -0.4% | -$800 | ﹤0.01% | 2632 |
|
|
2021
Q1 | $175K | Buy |
17,982
+48
| +0.3% | +$536 | ﹤0.01% | 2434 |
|
|
2020
Q4 | $184K | Sell |
17,934
-330
| -2% | -$3.34K | ﹤0.01% | 2323 |
|
|
2020
Q3 | $184K | Sell |
18,264
-416
| -2% | -$4.24K | ﹤0.01% | 2190 |
|
|
2020
Q2 | $195K | Buy |
18,680
+470
| +3% | +$4.86K | ﹤0.01% | 2133 |
|
|
2020
Q1 | $154K | Sell |
18,210
-1,052
| -5% | -$10.2K | ﹤0.01% | 2061 |
|
|
2019
Q4 | $169K | Sell |
19,262
-162
| -0.8% | -$1.34K | ﹤0.01% | 2315 |
|
|
2019
Q3 | $209K | Sell |
19,424
-135
| -0.7% | -$1.46K | ﹤0.01% | 2139 |
|
|
2019
Q2 | $249K | Buy |
19,559
+990
| +5% | +$22.8K | ﹤0.01% | 2097 |
|
|
2019
Q1 | $720K | Sell |
18,569
-603
| -3% | -$18.4K | ﹤0.01% | 1506 |
|
|
2018
Q4 | $390K | Sell |
19,172
-147
| -0.8% | -$4.41K | ﹤0.01% | 1814 |
|
|
2018
Q3 | $886K | Buy |
19,319
+348
| +2% | +$16.8K | ﹤0.01% | 1521 |
|
|
2018
Q2 | $1.12M | Buy |
18,971
+327
| +2% | +$18.9K | ﹤0.01% | 1309 |
|
|
2018
Q1 | $1.27M | Sell |
18,644
-709
| -4% | -$53.1K | ﹤0.01% | 1138 |
|
|
2017
Q4 | $1.91M | Buy |
19,353
+91
| +0.5% | +$10.2K | 0.01% | 1036 |
|
|
2017
Q3 | $2.31M | Buy |
19,262
+1,441
| +8% | +$134K | 0.01% | 934 |
|
|
2017
Q2 | $1.56M | Buy |
17,821
+890
| +5% | +$49.8K | 0.01% | 1060 |
|
|
2017
Q1 | $630K | Buy |
16,931
+2,733
| +19% | +$99.7K | ﹤0.01% | 1448 |
|
|
2016
Q4 | $436K | Sell |
14,198
-37
| -0.3% | -$1.6K | ﹤0.01% | 1717 |
|
|
2016
Q3 | $954K | Buy |
14,235
+21
| +0.1% | +$1.06K | ﹤0.01% | 1247 |
|
|
2016
Q2 | $423K | Buy |
14,214
+13,571
| +2,111% | +$424K | ﹤0.01% | 1681 |
|
|
2016
Q1 | $19K | Buy |
643
+11
| +2% | +$497 | ﹤0.01% | 4315 |
|
|
2015
Q4 | $50K | Buy |
632
+25
| +4% | +$1.96K | ﹤0.01% | 3910 |
|
|
2015
Q3 | $45K | Buy |
607
+56
| +10% | +$5.3K | ﹤0.01% | 3954 |
|
|
2015
Q2 | $64.3K | Sell |
551
-14,047
| -96% | -$2.54M | ﹤0.01% | 3939 |
|
|
2015
Q1 | $3.45M | Hold |
14,598
| – | – | 0.01% | 942 |
|
|
2014
Q4 | $2.76M | Sell |
14,598
-578
| -4% | -$128K | 0.01% | 996 |
|
|
2014
Q3 | $3.62M | Sell |
15,176
-11
| -0.1% | -$2.26K | 0.02% | 898 |
|
|
2014
Q2 | $1M | Buy |
15,187
+126
| +0.8% | +$8.96K | ﹤0.01% | 1588 |
|
|
2014
Q1 | $1.57M | Buy |
15,061
+362
| +2% | +$42.5K | 0.01% | 1242 |
|
|
2013
Q4 | $1.52M | Sell |
14,699
-147
| -1% | -$8.63K | 0.01% | 1206 |
|
|
2013
Q3 | $797K | Buy |
+14,846
| New | +$800K | ﹤0.01% | 1591 |
|
Other funds holding PBYI
CCM
ACM
AC
EP
American International Group's PBYI Position: Q2 2022 in Review
American International Group sold out of Puma Biotechnology (PBYI) in Q2 2022, closing a stake of 16,026 shares — an estimated $46K sold.
American International Group first reported a position in PBYI in Q3 2013 and held it in 35 quarters. The position peaked at $3.62M in Q3 2014. 88 funds tracked by Wall St. Rank hold PBYI as of Q2 2022.
- American International Group reported no remaining Puma Biotechnology position as of Q2 2022 after selling out during the quarter.
- American International Group sold 16,026 Puma Biotechnology shares in Q2 2022, an estimated $46K.
- American International Group first reported a position in Puma Biotechnology in Q3 2013 and held it in 35 quarters.
- American International Group's Puma Biotechnology position peaked at $3.62M in Q3 2014.
- 88 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2022.
Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.